Haifeng Wang1, Cameron D Wright2, John C Wain2, Harald C Ott2, Douglas J Mathisen3. 1. Massachusetts General Hospital, Boston, Massachusetts; Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. 2. Massachusetts General Hospital, Boston, Massachusetts. 3. Massachusetts General Hospital, Boston, Massachusetts. Electronic address: dmathisen@partners.org.
Abstract
BACKGROUND: Idiopathic subglottic stenosis is a rare inflammatory condition affecting the subglottic larynx. We have treated 263 patients (only 2 were male) with this condition. The purpose of this study is to determine factors affecting outcome and predisposing to complications. METHODS: Information was gathered from chart reviews, surveys, and a prospective database. RESULTS: Median time from diagnosis to surgery was 24 months. Antinuclear antibodies when measured were positive in 76 patients (47%). Prior tracheal procedures were done in 58 patients (22%), and 184 patients (70%) had prior endoscopic procedures. Resection of the posterior cricoid mucosa with tracheal membranous wall flap was done in 150 patients (57%). Tailored cricoplasty was performed in 105 patients (40%). Extubation in the operating room was achieved in 247 patients (94%). Steroid therapy for edema was required in 63 patients (24%). Anastomotic complications occurred in 30 patients, 17 granulations and 7 subcutaneous air. Twenty-three patients (8.7%) have recurrence (14 mild, 9 recalcitrant) requiring dilation. Risk factors for anastomotic complications and recurrence were edema requiring steroids, use of mitomycin C, and prior tracheostomy, stents, and vocal cord involvement. Follow-up was available for 227 patients. Follow-up survey of 180 patients revealed, on a 10-point scale, effectiveness 9.4, satisfaction 9.4, and symptom improvement 9.4. A normal voice was present in 82 patients (45%); 96 patients (54%) had change in voice; and 121 patients (67%) had difficulty projecting their voice. CONCLUSIONS: Single-stage reconstructive surgery resulted in 96% good-to-excellent results. Recalcitrant stenosis developed in 4% of patients. Stents, postoperative edema, mitomycin use, and vocal cord involvement are risks for recurrence. Recurrence was related to reactivation of disease in 14 patients and to technical problems in 6 patients.
BACKGROUND:Idiopathic subglottic stenosis is a rare inflammatory condition affecting the subglottic larynx. We have treated 263 patients (only 2 were male) with this condition. The purpose of this study is to determine factors affecting outcome and predisposing to complications. METHODS: Information was gathered from chart reviews, surveys, and a prospective database. RESULTS: Median time from diagnosis to surgery was 24 months. Antinuclear antibodies when measured were positive in 76 patients (47%). Prior tracheal procedures were done in 58 patients (22%), and 184 patients (70%) had prior endoscopic procedures. Resection of the posterior cricoid mucosa with tracheal membranous wall flap was done in 150 patients (57%). Tailored cricoplasty was performed in 105 patients (40%). Extubation in the operating room was achieved in 247 patients (94%). Steroid therapy for edema was required in 63 patients (24%). Anastomotic complications occurred in 30 patients, 17 granulations and 7 subcutaneous air. Twenty-three patients (8.7%) have recurrence (14 mild, 9 recalcitrant) requiring dilation. Risk factors for anastomotic complications and recurrence were edema requiring steroids, use of mitomycin C, and prior tracheostomy, stents, and vocal cord involvement. Follow-up was available for 227 patients. Follow-up survey of 180 patients revealed, on a 10-point scale, effectiveness 9.4, satisfaction 9.4, and symptom improvement 9.4. A normal voice was present in 82 patients (45%); 96 patients (54%) had change in voice; and 121 patients (67%) had difficulty projecting their voice. CONCLUSIONS: Single-stage reconstructive surgery resulted in 96% good-to-excellent results. Recalcitrant stenosis developed in 4% of patients. Stents, postoperative edema, mitomycin use, and vocal cord involvement are risks for recurrence. Recurrence was related to reactivation of disease in 14 patients and to technical problems in 6 patients.
Authors: Andreas Kirschbaum; Afshin Teymoortash; Carlos Suárez; Jatin P Shah; Carl E Silver; Iain Nixon; Alessandra Rinaldo; Luiz P Kowalski; K Thomas Robbins; Alfio Ferlito Journal: Auris Nasus Larynx Date: 2016-04-14 Impact factor: 1.863
Authors: Robert J Morrison; Nicolas-George Katsantonis; Kevin M Motz; Alexander T Hillel; C Gaelyn Garrett; James L Netterville; Christopher T Wootten; Susan M Majka; Timothy S Blackwell; Wonder P Drake; Alexander Gelbard Journal: Otolaryngol Head Neck Surg Date: 2018-10-16 Impact factor: 3.497
Authors: Ruth J Davis; Ioan Lina; Kevin Motz; Alexander Gelbard; Robert R Lorenz; Guri S Sandhu; Alexander T Hillel Journal: Otolaryngol Head Neck Surg Date: 2021-07-13 Impact factor: 5.591
Authors: Alexander Gelbard; Nicolas-George Katsantonis; Masanobu Mizuta; Dawn Newcomb; Joseph Rotsinger; Bernard Rousseau; James J Daniero; Eric S Edell; Dale C Ekbom; Jan L Kasperbauer; Alexander T Hillel; Liying Yang; C Gaelyn Garrett; James L Netterville; Christopher T Wootten; David O Francis; Charles Stratton; Kevin Jenkins; Tracy L McGregor; Jennifer A Gaddy; Timothy S Blackwell; Wonder P Drake Journal: Laryngoscope Date: 2016-06-14 Impact factor: 3.325
Authors: Nina Rahimi; Imme Roesner; Thomas Schweiger; Matthias Evermann; Doris-Maria Denk-Linnert; Walter Klepetko; Konrad Hoetzenecker Journal: Transl Cancer Res Date: 2020-03 Impact factor: 1.241